Prognostic Factors and Treatment Results of High-Grade Osteosarcoma in Norway: A Scope Beyond the “Classical” Patient
Open Access
Abstract
Purpose. A retrospective study of prognostic factors and treatment outcome of osteosarcoma (OS) during modern chemotherapy era with focus on patients with primary metastatic disease, nonextremity localisation, or age >40 years (nonclassical OS).Methods. A nationwide cohort, comprising 424 high-grade Norwegian bone OS patients, was based on registry sources supplemented with clinical records from hospitals involved in sarcoma management between 1975 and 2009.Results. Only 48% were younger patients with tumour in the extremities and without metastasis at diagnosis (classical OS). A considerable discrepancy in survival between classical and nonclassical OS was observed: 61% versus 26% 10-year sarcoma specific survival. Twice as many of the former received both adequate surgery and chemotherapy compared to the latter. This could only partly explain the differences in survival due to inherent chemoresistance in primary metastatic disease and a higher rate of local relapse among patients with axial tumours. Metastasis at diagnosis, increased lactate dehydrogenase, age > 40 years, and tumour size above median value were all adverse prognostic factors for overall survival.Conclusion. We confirm a dramatic difference in outcome between classical and nonclassical high-grade OS patients, but treatment variables could only partly explain the dismal outcome of the latter.Keywords
Funding Information
- National Resource Centre for Sarcomas in Norway
This publication has 76 references indexed in Scilit:
- Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trialsAnnals of Oncology, 2011
- Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcomaActa Orthopaedica, 2011
- Osteosarcoma: Time to move on?European Journal of Cancer, 2010
- Chemoradiotherapy in the treatment of inoperable high-grade osteosarcomaMedical Oncology, 2010
- Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Current strategies of chemotherapy in osteosarcomaInternational Orthopaedics, 2006
- Scandinavian Sarcoma Group Osteosarcoma Study SSG VIIIEuropean Journal of Cancer, 2003
- Osteosarcoma of the limbThe Journal of Bone and Joint Surgery. British volume, 2002
- The Will Rogers PhenomenonNew England Journal of Medicine, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958